-
公开(公告)号：US20110288109A1
公开(公告)日：2011-11-24
申请号：US13130069
申请日：2009-11-24
Applicant: Heinz Stadtmueller , Bodo Betzemeier , Ioannis Sapountzis
Inventor： Heinz Stadtmueller , Bodo Betzemeier , Ioannis Sapountzis
IPC: A61K31/506 , C07D401/14 , C07D417/14 , C07D403/12 , A61P37/06 , C07D413/14 , A61P35/00 , A61P31/00 , A61P29/00 , C07D401/12 , C07D405/14
CPC classification number: C07D417/14 , C07D239/47 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14 , C07D413/14
Abstract: The present invention includes compounds of general Formula (1), wherein A, X, R1 and R2 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
Abstract translation: 本发明包括通式（1）的化合物，其中A，X，R 1和R 2如权利要求1中所定义，其适用于治疗以细胞增殖过度或异常为特征的疾病及其用于制备药物 具有上述性质。
-
公开(公告)号：US20110237598A1
公开(公告)日：2011-09-29
申请号：US12893240
申请日：2010-09-29
Applicant: Heinz Stadtmueller , Ioannis Sapountzis
Inventor： Heinz Stadtmueller , Ioannis Sapountzis
IPC: A61K31/496 , C07D239/47 , A61K31/505 , C07D401/12 , A61K31/506 , C07D403/12 , A61P31/00 , A61P35/00 , A61P29/00
CPC classification number: C07D239/47 , C07D403/12 , C07D417/12
Abstract: The present invention encompasses compounds of general formulae (1a) and (1b) wherein the groups R1 to R5, A, Q, m, n, p and q are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use as medicaments.
Abstract translation: 本发明包括通式（1a）和（1b）的化合物，其中基团R 1至R 5，A，Q，m，n，p和q如权利要求1所定义，其适用于治疗以 过度或异常的细胞增殖，以及它们作为药物的用途。
-
3.发明申请DIAMINOPYRIDINES FOR THE TREATMENT OF DISEASES WHICH ARE CHARACTERISED BY EXCESSIVE OR ANOMAL CELL PROLIFERATION 有权用于治疗由过度或异常细胞增殖表征的疾病的二氨基嘧啶公开(公告)号：US20100305099A1
公开(公告)日：2010-12-02
申请号：US12743856
申请日：2008-12-02
Applicant: Ioannis Sapountzis , Juergen Braunger , Daniel Kuhn
Inventor： Ioannis Sapountzis , Juergen Braunger , Daniel Kuhn
IPC: A61K31/55 , C07D239/48 , C07D401/12 , C07D413/14 , C07D223/16 , A61K31/505 , A61K31/5377 , A61K31/506 , A61P35/04 , A61P35/00
CPC classification number: C07D239/48 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/14
Abstract: The present invention encompasses compounds of general formula (1) wherein A, B, R1-R3, Rx and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
Abstract translation: 本发明包括通式（1）的化合物，其中A，B，R1-R3，Rx和n如权利要求1中所定义，其适用于治疗以细胞增殖过度或异常为特征的疾病， 制备具有上述性质的药物。
-
公开(公告)号：US08846689B2
公开(公告)日：2014-09-30
申请号：US13130669
申请日：2009-11-24
Applicant: Heinz Stadtmueller , Ioannis Sapountzis
Inventor： Heinz Stadtmueller , Ioannis Sapountzis
IPC: A01N43/54 , C07D239/42 , C07D401/04
CPC classification number: C07D413/14 , C07D239/47 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D419/14 , C07D493/04
Abstract: The present invention encompasses compounds of general formula (1) wherein A, B, X, R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
Abstract translation: 本发明包括通式（1）的化合物，其中A，B，X，R 1至R 3如权利要求1中所定义，其适用于治疗以细胞增殖过度或异常为特征的疾病及其用于制备 具有上述特性的药物。
-
5.发明授权2,4-diaminopyrimidine derivates as PTK2-inhibitors for the treatment of abnormal cell growth 有权2,4-二氨基嘧啶衍生物作为治疗异常细胞生长的PTK2抑制剂公开(公告)号：US08377943B2
公开(公告)日：2013-02-19
申请号：US13128029
申请日：2009-11-13
Applicant: Ioannis Sapountzis , Bodo Betzemeier , Heinz Stadtmueller
Inventor： Ioannis Sapountzis , Bodo Betzemeier , Heinz Stadtmueller
IPC: A61K31/506 , C07D239/48
CPC classification number: C07D239/48 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12 , C07D413/14 , C07D453/02 , C07D471/04
Abstract: The present invention encompasses compounds of general formula (1) wherein R1-R3 and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
Abstract translation: 本发明包括通式（1）的化合物，其中R1-R3和n如权利要求1中所定义，其适用于治疗以细胞增殖过度或异常为特征的疾病及其用于制备具有上述药物的用途 提到的属性。
-
Patent Agency Ranking
公开(公告)号：US20110288071A1
公开(公告)日：2011-11-24
申请号：US13130669
申请日：2009-11-24
Applicant: Heinz Stadtmueller , Ioannis Sapountzis
Inventor： Heinz Stadtmueller , Ioannis Sapountzis
IPC: A61K31/553 , C07D401/12 , C07D403/12 , C07D413/12 , C07D239/47 , A61P31/00 , C07D401/14 , C07D413/14 , A61K31/513 , A61K31/5377 , A61P29/00 , A61P35/00 , C07D405/14 , C07D405/12
CPC classification number: C07D413/14 , C07D239/47 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D419/14 , C07D493/04
Abstract: The present invention encompasses compounds of general formula (1) wherein A, B, X, R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
Abstract translation: 本发明包括通式（1）的化合物，其中A，B，X，R 1至R 3如权利要求1中所定义，其适用于治疗以细胞增殖过度或异常为特征的疾病及其用于制备 具有上述特性的药物。
-
公开(公告)号：US20140038993A1
公开(公告)日：2014-02-06
申请号：US14049575
申请日：2013-10-09
Applicant: Heinz STADTMUELLER , Bodo BETZEMEIER , Ioannis SAPOUNTZIS
Inventor： Heinz STADTMUELLER , Bodo BETZEMEIER , Ioannis SAPOUNTZIS
IPC: C07D417/14 , C07D401/14 , C07D413/14 , C07D403/12 , C07D239/47 , C07D401/12 , C07D405/14
CPC classification number: C07D417/14 , C07D239/47 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14 , C07D413/14
Abstract: The present invention includes compounds of general formula (1) wherein A, X, R1 and R2 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
Abstract translation: 本发明包括通式（1）的化合物，其中A，X，R 1和R 2如权利要求1中所定义，其适用于治疗以细胞增殖过度或异常为特征的疾病，及其用于制备具有 上述属性。
-
8.发明授权Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation 有权用于治疗以过度或异常细胞增殖为特征的疾病的二氨基吡啶类公开(公告)号：US08461147B2
公开(公告)日：2013-06-11
申请号：US12743856
申请日：2008-12-02
Applicant: Ioannis Sapountzis , Juergen Braunger , Daniel Kuhn
Inventor： Ioannis Sapountzis , Juergen Braunger , Daniel Kuhn
IPC: C07D239/48 , C07D403/12 , A61K31/506
CPC classification number: C07D239/48 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/14
Abstract: The present invention encompasses compounds of general formula (1) wherein A, B, R1-R3, Rx and n are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
Abstract translation: 本发明包括通式（1）的化合物，其中A，B，R1-R3，Rx和n如权利要求1中所定义，其适用于治疗以细胞增殖过度或异常为特征的疾病， 制备具有上述性质的药物。
-
9.发明申请2,4-DIAMINOPYRIMIDINE DERIVATES AS PTK2- INHIBITORS FOR THE TREATMENT OF ABNORMAL CELL GROWTH 有权2,4-二氨基嘧啶衍生物作为治疗异常细胞生长的PTK2-抑制剂公开(公告)号：US20110275633A1
公开(公告)日：2011-11-10
申请号：US13128029
申请日：2009-11-13
Applicant: Ioannis Sapountzis , Bodo Betzemeier , Heinz Stadtmueller
Inventor： Ioannis Sapountzis , Bodo Betzemeier , Heinz Stadtmueller
IPC: A61K31/506 , C07D413/12 , C07D403/12 , C07D407/14 , A61P37/00 , A61K31/5377 , A61K31/496 , A61P35/00 , A61P29/00 , C07D401/12 , C07D413/14
CPC classification number: C07D239/48 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12 , C07D413/14 , C07D453/02 , C07D471/04
Abstract: The present invention encompasses compounds of general formula (1) wherein R1-R3 and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
Abstract translation: 本发明包括通式（1）的化合物，其中R1-R3和n如权利要求1中所定义，其适用于治疗以细胞增殖过度或异常为特征的疾病及其用于制备具有上述药物的用途 提到的属性。
-
公开(公告)号：US20110183952A1
公开(公告)日：2011-07-28
申请号：US12665769
申请日：2008-07-01
Applicant: Ioannis Sapountzis , Peter Ettmayer , Christian Klein , Andreas Mantoulidis , Steffen Steurer , Irene Waizenegger
Inventor： Ioannis Sapountzis , Peter Ettmayer , Christian Klein , Andreas Mantoulidis , Steffen Steurer , Irene Waizenegger
IPC: A61K31/397 , C07D401/14 , C07D413/14 , C07D249/04 , C07D403/14 , C07D243/08 , A61K31/4439 , A61K31/5377 , A61K31/4192 , A61K31/497 , A61K31/55 , A61K31/551 , A61P35/00 , A61P37/00
CPC classification number: C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14 , C07D417/04 , C07D417/14 , C07D487/08
Abstract: The present invention encompasses compounds of general formula (1), wherein the groups R1 to R3 and L are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
Abstract translation: 本发明包括通式（1）的化合物，其中R 1至R 3和L基团如权利要求1中所定义，其适用于治疗以细胞增殖过度或异常为特征的疾病及其用于制备药物 具有上述性质。
-
-
-
-
-
-
-
-
-
Search Results
22
records
(took 0.018 seconds)
